Provided by Tiger Trade Technology Pte. Ltd.

Insmed

121.51
-0.3100-0.25%
Post-market: 121.510.00000.00%19:39 EDT
Volume:1.42M
Turnover:171.69M
Market Cap:26.54B
PE:-29.72
High:122.19
Open:121.95
Low:119.52
Close:121.82
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:0.73
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:35.03
PE(LYR):-18.93

Loading ...

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-05-04

Reuters
·
May 04

Insmed presents late-breaking Phase 3b ENCORE ARIKAYCE data at ATS 2026

Reuters
·
May 04

Insmed price target raised to $214 from $212 at BofA

TIPRANKS
·
May 04

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Hims & Hers Health (HIMS) and Insmed (INSM)

TIPRANKS
·
May 04

Earning Preview: Insmed Q1 revenue is expected to increase by 227.48%, and institutional views are bullish

Earnings Agent
·
May 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD)

TIPRANKS
·
Apr 28

Insmed (INSM) Initiated with a Buy at Evercore ISI

TIPRANKS
·
Apr 27

If You Believe In Transformative AI Healthcare Then These Three Stocks Could Define Your Next Cycle

Simply Wall St.
·
Apr 27

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-24

Reuters
·
Apr 25

Insmed’s TPIP Extension Study Completion: What Long-Term PH-ILD Data Could Mean for INSM Investors

TIPRANKS
·
Apr 24

Insmed schedules first-quarter financial results conference call

Reuters
·
Apr 23

Insmed Chair, CEO William Lewis disposes of shares worth $1,532,026.22

Reuters
·
Apr 18

Insmed Price Target Maintained With a $212.00/Share by Roth Capital

Dow Jones
·
Apr 18

Insmed (INSM) Is Down 10.5% After Halting Brensocatib in HS Trial Miss - What's Changed

Simply Wall St.
·
Apr 17

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-16

Reuters
·
Apr 16

Is It Too Late To Consider Insmed (INSM) After A 109% One Year Surge?

Simply Wall St.
·
Apr 16

Insmed Sees Favorable Physician Feedback on Brinsupri, RBC Capital Markets Says

MT Newswires Live
·
Apr 14

Insmed Is Maintained at Outperform by RBC Capital

Dow Jones
·
Apr 14

RBC Raises Price Target on Insmed to $216 From $212, Keeps Outperform Rating

MT Newswires Live
·
Apr 14

Insmed Inc : RBC Raises Target Price to $216 From $212

THOMSON REUTERS
·
Apr 14